Viridian Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 02:59 am IST
Viridian Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 47.66 million compared to USD 28.91 million a year ago. Basic loss per share from continuing operations was USD 1.09 compared to USD 0.86 a year ago.
For the nine months, net loss was USD 170.87 million compared to USD 84.09 million a year ago. Basic loss per share from continuing operations was USD 3.97 compared to USD 2.88 a year ago.